Research Peptides NI

X CJC-1295 (No DAC) 10mg + Ipamorelin 10mg 20mg DCX Dual Chamber Research Pen

£120.00
£120.00
Sale

🧪 DCX Dual Chamber Exchange System – 20mg CJC-1295 (No DAC) / Ipamorelin Pen

Research Grade

🧾 PRODUCT OVERVIEW

Research Use Only – Not for Human or Animal Consumption

The DCX Dual Chamber Exchange System – 20mg CJC-1295 (No DAC) / Ipamorelin Pen is a compartmentalised research peptide blend system supplied for laboratory and in-vitro research purposes only.

This dual-chamber format is designed for controlled experimental investigation in laboratory environments, where separated material storage and controlled exchange processes may be evaluated within defined research models.

NI Peptides supplies this product exclusively as a research material and does not market it as a medicinal product.

⚗️ TECHNICAL SPECIFICATION

  • Compound: CJC-1295 (No DAC) / Ipamorelin
  • System Type: DCX Dual Chamber Exchange System
  • Format: Dual-chamber research pen system
  • Class: Research peptide blend
  • Quantity: 20mg total
  • Composition: CJC-1295 (No DAC) 10mg / Ipamorelin 10mg
  • Appearance: White/off-white lyophilised material
  • Purity: ≥ 98%
  • Storage: Store in a cool, dry environment
  • Post-activation storage: 2–8°C (where applicable)

🔬 DCX DUAL CHAMBER SYSTEM

The DCX Dual Chamber Exchange System utilises a separated dual-chamber configuration designed to maintain compartmentalisation of materials within a controlled laboratory setting.

This research format allows investigation into:

  • compartmentalised storage environments
  • controlled material separation
  • peptide stability under isolated conditions
  • exchange and activation processes within experimental systems

The dual-chamber design is intended for research applications where controlled handling and separated storage conditions are required during laboratory investigation.

All references to the DCX system relate strictly to non-clinical laboratory research functionality.

NI Peptides makes no representation regarding:

  • biological application
  • therapeutic use
  • clinical utility
  • diagnostic application

🔬 RESEARCH CONTEXT

CJC-1295 (No DAC) and Ipamorelin are distinct research peptides referenced within scientific literature and experimental laboratory settings. CJC-1295 (No DAC), commonly referred to as Modified GRF (1-29), is studied as a GHRH analogue, while Ipamorelin is a pentapeptide studied in relation to the ghrelin/GHS-R1a receptor pathway.

In controlled research settings, these compounds may be investigated in relation to:

  • peptide–receptor interaction dynamics
  • receptor-mediated signalling pathways
  • peptide stability and biochemical behaviour
  • molecular and cellular processes within experimental systems

Research involving these compounds is conducted strictly in non-clinical environments.

NI Peptides makes no representation regarding:

  • biological effects in humans or animals
  • clinical relevance
  • therapeutic or diagnostic application

All references to research relate strictly to experimental scientific investigation.

⚠️ IMPORTANT COMPLIANCE NOTICE

  • This product is NOT intended for human or veterinary use
  • This product is NOT a medicine
  • This product is not authorised as a medicinal product
  • This product has not been evaluated or approved by the MHRA
  • This product is NOT intended to diagnose, treat, cure, or prevent any disease

Any use outside legitimate laboratory research is strictly prohibited.

🧑🔬 PURCHASER DECLARATION

By purchasing this product, you confirm that:

  • You are acquiring this product for research purposes only
  • You are familiar with laboratory research practices
  • You understand this product is not for human or animal administration
  • You will comply with all applicable laws and regulations

🧊 HANDLING & STORAGE

  • Handle using appropriate laboratory procedures
  • Avoid repeated temperature fluctuation
  • Store under controlled laboratory conditions
  • Keep out of reach of unauthorised individuals

🚚 SHIPPING & PACKAGING

  • Secure, discreet packaging
  • Sealed research system to maintain product integrity
  • Batch identification where applicable

🔒 QUALITY ASSURANCE

Each batch is prepared in accordance with internal standards for research-grade materials.

Batch / purity data may be available upon request where applicable.

❗ DISCLAIMER

NI Peptides supplies the DCX Dual Chamber Exchange System strictly as a research compound system.

We do not:

  • provide dosage or administration guidance
  • make claims regarding outcomes or efficacy
  • endorse any use outside laboratory research